Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03932682
What this trial is testing

Efficacy Study With QIVc in Pediatric Subjects

Who this might be right for
Influenza, Human
Seqirus 5,723
Large-scale testing (Phase 3)Study completedNCT05559476
What this trial is testing

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,029
Post-approval studies (Phase 4)Study completedNCT06024096
What this trial is testing

Systems Biological Assessment of Statin Effect on Vaccine Responses

Who this might be right for
Vaccine Response
Emory University 63
Post-approval studies (Phase 4)Study completedNCT01946425
What this trial is testing

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT05624606
What this trial is testing

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 682
Large-scale testing (Phase 3)Study completedNCT04381689
What this trial is testing

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 260
Large-scale testing (Phase 3)Ended earlyNCT05513391
What this trial is testing

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 366
Testing effectiveness (Phase 2)Ended earlyNCT01195779
What this trial is testing

Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 4
Testing effectiveness (Phase 2)Study completedNCT05284799
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in Healthy Volunteers.

Who this might be right for
Influenza
Osivax 180
Large-scale testing (Phase 3)Study completedNCT03927131
What this trial is testing

Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Who this might be right for
Influenza, Human
Butantan Institute 5,822
Not applicableStudy completedNCT05832333
What this trial is testing

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

Who this might be right for
Influenza
Sanofi 682
Large-scale testing (Phase 3)Study completedNCT03739112
What this trial is testing

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more
Medicago 12,794
Large-scale testing (Phase 3)Study completedNCT01712984
What this trial is testing

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 3,360
Testing effectiveness (Phase 2)Study completedNCT01561768
What this trial is testing

Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults

Who this might be right for
Influenza
Novavax 500
Post-approval studies (Phase 4)Study completedNCT05154383
What this trial is testing

Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression

Who this might be right for
Vaccine Reaction
Centre Hospitalier Annecy Genevois 60
Large-scale testing (Phase 3)Looking for participantsNCT07211152
What this trial is testing

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 150
Early research (Phase 1)Study completedNCT02708173
What this trial is testing

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Who this might be right for
Quadrivalent Influenza Virus Vaccine
Beijing Chaoyang District Centre for Disease Control and Prevention 40
Large-scale testing (Phase 3)Study completedNCT04120194
What this trial is testing

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Who this might be right for
Influenza, Human
Novavax 2,654
Large-scale testing (Phase 3)Study completedNCT03391193
What this trial is testing

Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 301
Large-scale testing (Phase 3)Study completedNCT01440387
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 112
Next Page